Buscar
Mostrando ítems 1-10 de 1423
PARATHYROID-HORMONE SECRETORY RESERVE IN PATIENTS SUBMITTED TO 131-IODINE THERAPY FOR HYPERTHYROIDISM
(Assoc Bras Divulg Cientifica, 1991-01-01)
Twelve euthyroid patients who had been treated with I-131 for hyperthyroidism due to Graves' disease and six normal controls were submitted to an EDTA infusion test. Ionized calcium and parathyroid hormone were measured ...
Does radioiodine therapy in patients with differentiated thyroid cancer increase the frequency of another malignant neoplasm?
(Isrn Oncology, 2011)
Objectives. To compare the frequency of another primary malignancy in patients with differentiated thyroid carcinoma (DTC) who received radioiodine therapy or not ((131)I). Material and Methods. 168 cases of DTC patients ...
High pre-therapy [Tc-99m]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in [I-131]iodide therapy in Graves' disease
(Lippincott Williams & WilkinsPhiladelphiaEUA, 2005)
Predictive Factors of Failure in a Fixed 15 mCi I-131-Iodide Therapy for Graves' Disease
(Lippincott Williams & WilkinsPhiladelphia, 2012)
Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease
(Mary Ann Liebert Inc PublLarchmontEUA, 2004)